RVL Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. RVL Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 184% to $49,721,000. The net income raised on -$51,692,000 and profit margin reached -104%. Total operating expenses were $85,945,000.
Profit Margin
| 2016 | 218.45M | -41.82M | -19.14% |
|---|---|---|---|
| 2017 | 245.74M | -45.15M | -18.37% |
| 2018 | 263.70M | -109.68M | -41.59% |
| 2019 | 240.03M | -270.90M | -112.86% |
| 2020 | 27.76M | -89.01M | -320.63% |
| 2021 | 17.50M | -82.84M | -473.4% |
| 2022 | 49.72M | -51.69M | -103.96% |
RVLP Income Statement (2016 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 49.72M | 17.50M | 27.76M | 240.03M | 263.70M | 245.74M | 218.45M |
Cost of revenue | 9.45M | 3.61M | 3.29M | 111.63M | 140.08M | 125.18M | 125.61M |
Gross profit | 40.26M | 13.88M | 24.46M | 128.40M | 123.61M | 120.56M | 92.84M |
Operating exp. | |||||||
Research and development | 3.96M | 6.93M | 13.38M | 32.31M | 43.69M | 42.68M | 29.06M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 85.94M | 94.39M | 86.21M | 125.34M | 117.93M | 99.64M | 95.01M |
Operating income | -45.68M | -80.51M | -61.74M | 3.93M | -98.53M | -52.06M | -32.04M |
Other income (expenses), net | -6.03M | -2.02M | -33.05M | -301.95M | -103.55M | -33.57M | -29.70M |
Income before tax | -51.71M | -82.53M | -94.79M | -298.02M | -118.66M | -85.64M | -52.06M |
Income tax expense | -20K | 315K | -5.78M | -27.12M | -8.98M | -40.48M | -10.24M |
Net income | -51.69M | -82.84M | -89.01M | -270.90M | -109.68M | -45.15M | -41.82M |
Earnings per share | |||||||
Basic EPS | -0.58 | -1.23 | -1.47 | -5.17 | -2.42 | -1.05 | -0.98 |
Diluted EPS | -0.58 | -1.23 | -1.47 | -5.17 | -2.42 | -0.98 | -0.98 |
| Data source | Data source | Data source | Data source | Data source |